Zoetis Inc   (ZTS)
Other Ticker:  
Price: $186.5500 $-1.84 -0.977%
Day's High: $189.41 Week Perf: 1.67 %
Day's Low: $ 186.24 30 Day Perf: -0.97 %
Volume (M): 2,503 52 Wk High: $ 201.92
Volume (M$): $ 466,879 52 Wk Avg: $177.92
Open: $187.30 52 Wk Low: $151.08

 Market Capitalization (Millions $) 86,247
 Shares Outstanding (Millions) 462
 Employees 12,100
 Revenues (TTM) (Millions $) 8,544
 Net Income (TTM) (Millions $) 2,340
 Cash Flow (TTM) (Millions $) -1,540
 Capital Exp. (TTM) (Millions $) 732

Zoetis Inc
Zoetis Inc is a leading animal health company with a global presence that offers various products and services to animal owners, veterinarians, and farmers. The company is committed to improving the health and wellbeing of animals and strives to create sustainable, integrated animal health solutions.

Headquartered in Parsippany, New Jersey, Zoetis was founded in 1952 as a division of Pfizer Inc. and became an independent company in 2013 through an initial public offering (IPO). It has since grown to become a leading animal health company with nearly 10,000 employees and a presence in over 100 countries.

The company's diverse portfolio of products and services includes vaccines, parasiticides, anti-infectives, and other pharmaceuticals for livestock, poultry, companion animals, and aquaculture. Zoetis also provides diagnostic products and services, genetic testing, and a range of digital health tools to support animal healthcare professionals in making informed decisions.

Zoetis operates through four main business segments: United States, International, Cattle, and Other. The company's largest business segment, the United States, offers a wide range of products and services for the care and wellbeing of dogs, cats, horses, and livestock. The International segment provides animal health products, services, and solutions to customers globally. The Cattle segment focuses on cattle health and wellbeing with products for the prevention and treatment of diseases and parasites. The Other segment includes products and services for aquaculture and other species.

Zoetis manufactures and distributes its products through a network of distributors, veterinarians, and animal healthcare professionals. The company is committed to research and development and invests heavily in developing new products and improving existing ones. It has a strong pipeline of products in development and partnerships with leading research institutions, ensuring continued innovation in animal health.

In addition to its commitment to animal health, Zoetis is also dedicated to corporate social responsibility initiatives. These include sustainability efforts to reduce its impact on the environment, employee volunteerism campaigns, and partnerships with organizations that support animal health and wellbeing.

Overall, Zoetis Inc is a global leader in animal health with a comprehensive portfolio of animal health products, digital solutions, and diagnostic services. It is committed to improving animal health and wellbeing, while also promoting sustainable practices and supporting communities.

   Company Address: 10 Sylvan Way, Parsippany, 7054 NJ
   Company Phone Number: 822-7000   Stock Exchange / Ticker: NYSE ZTS
    Next quarterly dividend pay out on March 01, 2024.


Stock Performances by Major Competitors

5 Days Decrease / Increase
• View Complete Report

Zoetis Inc

Zoetis Inc. Dominates Fourth Quarter 2023 Earnings Season with Exceptional Financial Performance

As a financial analyst for the , I am pleased to interpret the recent financial results of Zoetis Inc., a major pharmaceutical preparations company that specializes in animal health. Looking at the fiscal span ending December 31, 2023, it is evident that Zoetis Inc. has made significant strides in terms of revenue and earnings growth.
The company reported a revenue increase of 8.48% to $2.21 billion, compared to $2.04 billion in the prior year. This impressive revenue growth outperformed its industry peers, who only saw an average increase of 3.08% during the same period. Additionally, Zoetis Inc. posted earnings growth of 15.51% to $1.14 per share, up from $0.99 in the previous year. These results indicate that Zoetis Inc. is managing its finances efficiently and effectively, leading to improved profitability.


Zoetis Inc. Announces Dividend Decline in Second Quarter 2024, but Remains Strong in Healthcare Sector

Published Tue, Feb 6 2024 9:15 PM UTC

Intro: In an exciting development for shareholders, Zoetis Inc., the world's leading animal health company, has declared its dividend for the second quarter of 2024. Despite a decrease in their dividend pay-out ratio, Zoetis Inc. continues to outperform its peers in the healthcare sector. This article will delve into the details of the announcement and assess its impact...


Zoetis Inc. Announces 15% Dividend Increase for Q1 2024, Reinforcing Strong Financial Performance in Animal Health Sector

Published Thu, Dec 7 2023 9:05 PM UTC

In a recent press release, Zoetis Inc., a leading global animal health company, has declared a dividend of $0.432 per share for the first quarter of 2024. This marks a significant 15% increase from the previous quarterly dividend rate paid in 2023. The dividend is scheduled to be paid on March 1, 2024, to all holders of record as of January 19, 2024.
The decision to...

Zoetis Inc

Zoetis Inc. Dominates Market with Impressive 7% Revenue Growth in Third Quarter

Zoetis Inc. Reports Strong Quarter with Revenue Increase of 7%
Zoetis Inc., a leading animal health company, has announced its financial results for the third quarter of 2023. The company recorded a significant increase in revenue, showcasing its continued growth and success in the market.
In comparison to the prior year reporting period, Zoetis Inc. saw a revenue increase of 7.443% to $2.15 billion. This growth demonstrates the company's ability to generate substantial income and gain traction in the market. Additionally, income per share grew by 14.16% to $1.29 per share, further highlighting the company's strong performance.


Zoetis Inc. Demonstrates Financial Resilience with Fourth Quarter 2023 Dividend Declaration

Published Thu, Oct 12 2023 8:15 PM UTC

Zoetis Inc., the world's leading animal health company, has declared a quarterly dividend of $0.375 per share for the fourth quarter of 2023. The dividend payout is a testament to the company's commitment to nurturing the world and advancing care for animals. This article will provide an overview of the dividend announcement and analyze Zoetis's financial performan...


Zoetis Inc's Segments
• View Complete Report
  Company Estimates  
  Revenue Outlook
Zoetis Inc does not provide revenue guidance.

Earnings Outlook
Zoetis Inc does not provide earnings estimates.

Geographic Revenue Dispersion


About us


CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com